Gut microbiota dysbiosis exacerbates acute pancreatitis via Escherichia coli -driven neutrophil heterogeneity and NETosis
Authors:
Open Access
- 24 December 2025
- journal article
- Published by Taylor & Francis in Gut Microbes
- Vol. 18 (1) , 2606480
Abstract
Gut microbiota dysbiosis contributes to acute pancreatitis (AP) severity, but the specific microbes and mechanisms remain unclear. In this study, we employed both germ-free (GF) and specific-pathogen-free (SPF) murine models of AP to investigate the role of the intestinal microbiota. Our findings demonstrate that GF mice exhibited markedly attenuated pancreatic injury, inflammatory cell infiltration, and neutrophil extracellular traps (NETs) formation. Through fecal microbiota transplantation (FMT) from AP patients, differential antibiotic modulation, and single-bacterial colonization experiments, we identified Gram-negative bacteria, particularly Escherichia coli (E. coli), as critical microbial drivers of disease exacerbation. Single-cell RNA sequencing revealed that microbiota dysbiosis profoundly reprogrammed both local pancreatic and systemic immune landscapes. Specifically, dysbiosis promoted emergency granulopoiesis in the bone marrow, enhanced neutrophil mobilization and activation, and facilitated the expansion of pro-inflammatory neutrophil subpopulations (Neutrophils_2 and Neutrophils_3). These subsets exhibited upregulated signaling through NETosis-associated pathways, including TLR, NF-κB, and IL-17 axes. Conversely, in GF conditions, we observed a predominance of an anti-inflammatory neutrophil subset (Neutrophils_4), characterized by the expression of tissue repair-associated genes such as Reg1 and Reg2. Shotgun metagenomic profiling of fecal samples from patients with AP revealed an enrichment of E. coli during the acute phase, positively correlating with circulating cell-free DNA, a marker of NETosis. Together, these insights suggest that gut microbiota dysbiosis, notably increased E. coli abundance, may aggravate AP by reshaping immunity and promoting aberrant NETs formation, supporting microbiota or NETs targeted therapies.Keywords
Funding Information
- National Natural Science Foundation of China (81960128)
- the Science and Technology Innovation Team Cultivation Project of the First Affiliated Hospital of Nanchang University (YFYKCTDPY202202)
- the Double-Thousand Plan of Jiangxi Province (jxsq2019201028)
- the Jiangxi Medicine Academy of Nutrition and Health Management (2022-PYXM-01)
This publication has 53 references indexed in Scilit:
- Gut-microbiota-derived indole sulfate promotes heart failure in chronic kidney diseaseCell Host & Microbe, 2025
- A Single‐Cell Atlas‐Inspired Hitchhiking Therapeutic Strategy for Acute Pancreatitis by Restricting ROS in NeutrophilsAdvanced Materials, 2025
- Gut microbiota controls the development of chronic pancreatitis: A critical role of short-chain fatty acids-producing Gram-positive bacteriaActa Pharmaceutica Sinica B, 2023
- Vascular traffic control of neutrophil recruitment to the liver by microbiota-endothelium crosstalkCell Reports, 2023
- Gut microbiome dysbiosis contributes to abdominal aortic aneurysm by promoting neutrophil extracellular trap formationCell Host & Microbe, 2022
- Gut-microbiota-targeted diets modulate human immune statusCell, 2021
- Gastrointestinal Failure Is a Predictor of Poor Outcome in Patients with Acute PancreatitisDigestive Diseases and Sciences, 2019
- Gut microbiota dysbiosis worsens the severity of acute pancreatitis in patients and miceJournal of Gastroenterology, 2018
- Gut Microbiota Promote Hematopoiesis to Control Bacterial InfectionCell Host & Microbe, 2014
- An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune SystemCell, 2005